GlassScriptPhysician profile
Arlie Massillon
NPI 1073742243
$1,244.99
in general payments reported to CMS, 2019-2025
15 companies · $57.89 in 2025
The $57.89 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $344 · 2022: $317 · 2023: $382 · 2024: $144 · 2025: $57.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $275.59 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $211.53 | 2021-2023 | |
| Agile Therapeutics, INC. | $188.06 | 2021-2024 | Twirla |
| Myriad Women'S Health, INC. | $100.60 | 2023 | Myrisk |
| Scynexis, INC. | $80.91 | 2022 | |
| Astellas Pharma US INC | $79.00 | 2022-2025 | Vesicare, Veozah |
| Exact Sciences Corporation | $78.17 | 2023-2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $40.41 | 2021-2022 | |
| Myovant Sciences INC. | $37.12 | 2022 | |
| Evofem Biosciences, INC. | $35.53 | 2023-2024 | Phexxi |
| Organon LLC | $24.74 | 2021 | |
| Sumitomo Pharma America, INC. | $23.75 | 2024 | Myfembree |
| Lupin INC. | $23.73 | 2021 | |
| Hologic Sales and Service, LLC | $23.56 | 2025 | Aptima |
| Pfizer INC. | $22.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlie Massillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.